
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"... Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0021 | 0.0021 | 0.0021 | 227 | 0.0021 | CS |
4 | 0 | 0 | 0.0021 | 0.0305 | 0.0006 | 294 | 0.00191095 | CS |
12 | -0.0005 | -19.2307692308 | 0.0026 | 0.0861 | 0.0005 | 1561 | 0.00372198 | CS |
26 | -0.0001 | -4.54545454545 | 0.0022 | 0.0861 | 0.0004 | 1598 | 0.00441566 | CS |
52 | -0.1479 | -98.6 | 0.15 | 0.56 | 1.0E-6 | 3811 | 0.18269999 | CS |
156 | -2.7479 | -99.9236363636 | 2.75 | 2.75 | 1.0E-6 | 658697 | 0.02419298 | CS |
260 | -0.0034 | -61.8181818182 | 0.0055 | 2.75 | 1.0E-6 | 637449 | 0.02419298 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約